• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: KANEKA CORP. LIPOSORBER LA-15 SYSTEM; LDL APHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

KANEKA CORP. LIPOSORBER LA-15 SYSTEM; LDL APHERESIS SYSTEM Back to Search Results
Model Number LA-15
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Apheresis (1719); Death (1802); Tachycardia (2095)
Event Date 10/18/2014
Event Type  Death  
Event Description
The ldl-apheresis with the liposorber la-15 system (ldl-a) applied to the (b)(6) female patient (pt) for the treatment of her arterio sclerosis obliterans (aso).It was her 6th ldl-a in the 2nd session (one session usually consists of 10 times of ldl-a).The pt was on chronic hemodialysis (hd), 3 times per week, on monday, wednesday and friday, and this ldl-a was conducted on saturday in the late afternoon.The ldl-a was completed without complication except for a slight tachycardia of over 100/min.(usually in around 70/min.During ldl-a) and she went home as usual.In the late afternoon of the next day, she suffered from severe dyspnea and was transferred by an ambulance to a general hospital, that is different from the site where her ldl-a has been conducted.The family member of the pt made a phone call to the physician in charge for her ldl-a and informed of her passing away.No further information is available from the patient's family.
 
Manufacturer Narrative
No information about the cause of the patient's death was available to the physician in charge for the patient's ldl-a, and according to us, and if the ldl-a was relevant to the patient's death could not be judged.The ldl-a on the day before the patient's death was completed without complications, and accordingly, we believe that no defect or malfunction of the devices used occurred during the ldl-a.It is well known that patients with arteriosclerosis obliterance (aso), or peripheral arterial occlusive disease (paod), have complications such as coronary and/or cerebral artery diseases, and also that chronic hemodialysis (hd) patients have higher risk for heart failure, cerebral vascular diseases and myocardial infarction.The device history record (dhr) of the la-15 with lot no.Lap1340 (speculated from the device record at the local distributor) was reviewed and no nonconformity or abnormality was found in its manufacturing processes.The device met its material, assembling and product specifications.Accordingly, we believe that the ldl-a was not relevant to the patient's death and a sudden aggravation of the underling disease(s) and or complication(s) may be responsible to the patient's death.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIPOSORBER LA-15 SYSTEM
Type of Device
LDL APHERESIS SYSTEM
Manufacturer (Section D)
KANEKA CORP.
osaka
JA 
Manufacturer (Section G)
KANEKA CORP.
Manufacturer Contact
masaharu inoue
546 fifth ave.
21st floor
new york, NY 10036
8005263522
MDR Report Key4274192
MDR Text Key5030414
Report Number9614654-2014-00013
Device Sequence Number1
Product Code MMY
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P910018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign
Reporter Occupation Physician
Type of Report Initial
Report Date 11/17/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2018
Device Model NumberLA-15
Device Lot NumberLAP1340 (SPECULATED)
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/19/2014
Initial Date FDA Received11/17/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
APHERESIS MACHINE KANEKA MA-03 (NIKKISO CO. LTD); PLASMA SEPARATOR; TUBING SYSTEM FOR PLASMAPHERESIS NK-M3R; (NIKKISO CO. LTD); SULFLUX FP-05 (ASAHI-KASEI MEDICAL CO. LTD)
Patient Outcome(s) Death;
Patient Age59 YR
Patient Weight65
-
-